Annual Total Long Term Liabilities
$2.99 M
-$1.09 M-26.73%
December 31, 2024
Summary
- As of March 10, 2025, JSPR annual total long term liabilities is $2.99 million, with the most recent change of -$1.09 million (-26.73%) on December 31, 2024.
- During the last 3 years, JSPR annual total long term liabilities has fallen by -$13.13 million (-81.46%).
- JSPR annual total long term liabilities is now -94.51% below its all-time high of $54.48 million, reached on December 31, 2020.
Performance
JSPR Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$2.99 M
-$286.00 K-8.74%
December 31, 2024
Summary
- As of March 10, 2025, JSPR quarterly total long term liabilities is $2.99 million, with the most recent change of -$286.00 thousand (-8.74%) on December 31, 2024.
- Over the past year, JSPR quarterly long term liabilities has stayed the same.
- JSPR quarterly long term liabilities is now -94.51% below its all-time high of $54.48 million, reached on December 31, 2020.
Performance
JSPR Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
JSPR Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.7% | 0.0% |
| 3 y3 years | -81.5% | -31.6% |
| 5 y5 years | -94.5% | -31.6% |
JSPR Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -81.5% | at low | -81.5% | at low |
| 5 y | 5-year | -94.5% | at low | -94.5% | at low |
| alltime | all time | -94.5% | at low | -94.5% | at low |
Jasper Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.99 M(-26.7%) | $2.99 M(-8.7%) |
| Sep 2024 | - | $3.27 M(-7.8%) |
| Jun 2024 | - | $3.55 M(-7.0%) |
| Mar 2024 | - | $3.82 M(-6.4%) |
| Dec 2023 | $4.08 M | $4.08 M(-6.6%) |
| Sep 2023 | - | $4.37 M(-12.6%) |
| Jun 2023 | - | $4.99 M(-11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $5.67 M(+6.8%) |
| Dec 2022 | $5.31 M(-67.1%) | $5.31 M(+28.7%) |
| Sep 2022 | - | $4.12 M(-16.9%) |
| Jun 2022 | - | $4.96 M(-23.3%) |
| Mar 2022 | - | $6.47 M(-59.8%) |
| Dec 2021 | $16.12 M(-70.4%) | $16.12 M(-17.1%) |
| Sep 2021 | - | $19.45 M(-64.3%) |
| Dec 2020 | $54.48 M | $54.48 M |
FAQ
- What is Jasper Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Jasper Therapeutics?
- What is Jasper Therapeutics annual total long term liabilities year-on-year change?
- What is Jasper Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly long term liabilities year-on-year change?
What is Jasper Therapeutics annual total long term liabilities?
The current annual total long term liabilities of JSPR is $2.99 M
What is the all time high annual total long term liabilities for Jasper Therapeutics?
Jasper Therapeutics all-time high annual total long term liabilities is $54.48 M
What is Jasper Therapeutics annual total long term liabilities year-on-year change?
Over the past year, JSPR annual total long term liabilities has changed by -$1.09 M (-26.73%)
What is Jasper Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of JSPR is $2.99 M
What is the all time high quarterly long term liabilities for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly total long term liabilities is $54.48 M
What is Jasper Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, JSPR quarterly total long term liabilities has changed by $0.00 (0.00%)